Patexia Research

Case number 1:19-cv-00105

Lawsuits

Genentech, Inc. et al v. Aurobindo Pharma Limited et al > Summary

Court Case Number 1:19-cv-00105

Filing Date Jan 17, 2019

Termination Date Oct 20, 2021

Court Delaware District Court

Status Dismissed - Settled

JudgesRichard G. Andrews

Plaintiff

2

Defendant

2

Aurobindo Pharma

Aurobindo Pharma USA

Plaintiff Attorneys

22

Genentech, Inc
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell

Genentech, Inc
Attorney Name: Ryan N. Hagglund
Loeb & Loeb

Genentech, Inc
Attorney Name: Karen Ann Jacobs
Morris Nichols Arsht & Tunnell

Genentech, Inc
Attorney Name: Warren K. MacRae
Loeb & Loeb

Genentech, Inc
Attorney Name: Mark E. Waddell
Loeb & Loeb

InterMune
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell

InterMune
Attorney Name: Ryan N. Hagglund
Loeb & Loeb

InterMune
Attorney Name: Karen Ann Jacobs
Morris Nichols Arsht & Tunnell

InterMune
Attorney Name: Warren K. MacRae
Loeb & Loeb

InterMune
Attorney Name: Mark E. Waddell
Loeb & Loeb

Genentech, Inc
Attorney Name: Jack B. Blumenfeld

Genentech, Inc
Attorney Name: Ryan N. Hagglund

Genentech, Inc
Attorney Name: Karen Ann Jacobs

Genentech, Inc
Attorney Name: Warren K. MacRae

Genentech, Inc
Attorney Name: Mark E. Waddell

InterMune
Attorney Name: Jack B. Blumenfeld

InterMune
Attorney Name: Ryan N. Hagglund

InterMune
Attorney Name: Karen Ann Jacobs

InterMune
Attorney Name: Warren K. MacRae

InterMune
Attorney Name: Mark E. Waddell

Genentech, Inc
Attorney Name: Jack B. Blumenfeld

InterMune
Attorney Name: Jack B. Blumenfeld

Defendant Attorneys

3

Aurobindo Pharma
Attorney Name: Kenneth L. Dorsney
Morris James LLP

Aurobindo Pharma
Attorney Name: Kenneth L. Dorsney

Aurobindo Pharma USA
Attorney Name: Kenneth L. Dorsney

Counter Defendant

10

Genentech, Inc
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell

Genentech, Inc
Attorney Name: Karen Ann Jacobs
Morris Nichols Arsht & Tunnell

InterMune
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell

InterMune
Attorney Name: Karen Ann Jacobs
Morris Nichols Arsht & Tunnell

Genentech, Inc
Attorney Name: Jack B. Blumenfeld

Genentech, Inc
Attorney Name: Karen Ann Jacobs

InterMune
Attorney Name: Jack B. Blumenfeld

InterMune
Attorney Name: Karen Ann Jacobs

Genentech, Inc
Attorney Name: Jack B. Blumenfeld

InterMune
Attorney Name: Jack B. Blumenfeld

Counter Claimant

3

Aurobindo Pharma USA
Attorney Name: Kenneth L. Dorsney
Morris James LLP

Aurobindo Pharma USA
Attorney Name: Kenneth L. Dorsney

Aurobindo Pharma
Attorney Name: Kenneth L. Dorsney

Cause

35:271 Patent Infringement

Related Patents

Doc No	Title	Issue date
09561217	Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1H)-pyridone	Feb 7, 2017
08778947	Methods of administering pirfenidone therapy	Jul 15, 2014
08754109	Pirfenidone therapy and inducers of cytochrome P450	Jun 17, 2014
08648098	Pirfenidone therapy and inducers of cytochrome P450	Feb 11, 2014
08609701	Pirfenidone treatment for patients with atypical liver function	Dec 17, 2013
08592462	Pirfenidone treatment for patients with atypical liver function	Nov 26, 2013
08420674	Method of providing pirfenidone therapy to a patient	Apr 16, 2013
08383150	Granulate formulation of pirfenidone and pharmaceutically acceptable excipients	Feb 26, 2013
08318780	Methods of administering pirfenidone therapy	Nov 27, 2012
08084475	Pirfenidone therapy and inducers of cytochrome P450	Dec 27, 2011
08013002	Methods of administering pirfenidone therapy	Sep 6, 2011
07910610	Methods of administering pirfenidone therapy	Mar 22, 2011
07816383	Methods of administering pirfenidone therapy	Oct 19, 2010
07767700	Method of providing pirfenidone therapy to a patient	Aug 3, 2010
07635707	Pirfenidone treatment for patients with atypical liver function	Dec 22, 2009
07566729	Modifying pirfenidone treatment for patients with atypical liver function	Jul 28, 2009